Fibrocytes are involved in the pathogenesis of human chronic kidney disease

Human Pathology

Volumn 41, Issue 5, 2010, Pages 672-678

  Sakai, Norihiko ^a   Furuichi, Kengo ^a   Shinozaki, Yasuyuki ^b   Yamauchi, Hiroyuki ^b   Toyama, Tadashi ^b   Kitajima, Shinji ^b   Okumura, Toshiya ^b   Kokubo, Satoshi ^b   Kobayashi, Motoo ^b   Takasawa, Kazuya ^c   Takeda, Shin ichi ^d   Yoshimura, Mitsuhiro ^e   Kaneko, Shuichi ^b   Wada, Takashi ^b  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b Faculty of Health Sciences   (Japan)

^c Public Central Hospital of Matto Ishikawa   (Japan)

^d Department of Internal Medicine   (Japan)

^e NATIONAL HOSPITAL ORGANIZATION KANAZAWA MEDICAL CENTER   (Japan)

Author keywords

Chemokine; CKD; Fibrocytes; Fibrosis

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; CELL INFILTRATION; CHRONIC KIDNEY DISEASE; CONNECTIVE TISSUE CELL; CONVALESCENCE; CRESCENTIC GLOMERULONEPHRITIS; DIABETIC NEPHROPATHY; FEMALE; FIBROCYTE; FIBROSING ALVEOLITIS; GLOMERULONEPHRITIS; GLOMERULOPATHY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; INTERSTITIUM; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROSCLEROSIS; OBESITY RELATED GLOMERULOPATHY; PATHOGENESIS; PROTEIN URINE LEVEL; THIN BASEMENT MEMBRANE DISEASE;

ADULT; AGED; ANALYSIS OF VARIANCE; CHEMOKINES; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MACROPHAGES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 77950594447     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2009.10.008     Document Type: Article

References (35)

1. Stenvinkel P., Carrero J.J., Axelsson J., et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?. Clin J Am Soc Nephrol 3 (2008) 505-521
2. Nath K.A. The tubulointerstitium in progressive renal disease. Kidney Int 54 (1998) 992-994
3. Zeisberg M., Hanai J., Sugimoto H., et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med 9 (2003) 964-968
4. Kitagawa K., Wada T., Furuichi K., et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am J Pathol 165 (2004) 237-246
5. Phillips R.J., Burdick M.D., Hong K., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114 (2004) 438-446
6. Sakai N., Wada T., Yokoyama H., et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103 (2006) 14098-14103
7. Kisseleva T., Uchinami H., Feirt N., et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45 (2006) 429-438
8. Abe R., Donnelly S.C., Peng T., et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166 (2001) 7556-7562
9. Wada T., and Sakai N. Matsushima, et al. Fibrocytes: a new insight into kidney fibrosis. Kidney Int 72 (2007) 269-273
10. Chesney J., Metz C., Stavitsky A.B., et al. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160 (1998) 419-425
11. Bucala R., Spiegel L.A., Chesney J., et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1 (1994) 71-81
12. Bucala R. Circulating fibrocytes: cellular basis for NSF. J Am Coll Radiol 5 (2008) 36-39
13. Schmidt M., Sun G., Stacey M.A., et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 171 (2003) 380-389
14. Yang L., Scott P.G., Giuffre J., et al. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 82 (2002) 1183-1192
15. Sakai N., Wada T., Matsushima K., et al. The renin-angiotensin system contributes to renal fibrosis through regulation of fibrocytes. J Hypertens 26 (2008) 780-790
16. Moore B.B., Kolodsick J.E., Thannickal V.J., et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166 (2005) 675-684
17. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100
18. Yokoyama H., Wada T., Hara A., et al. The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int 66 (2004) 2382-2388
19. Iseki K., Horio M., Imai E., et al. Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa. Clin Exp Nephrol 13 (2009) 44-49
20. Sakai N., Wada T., Furuichi K., et al. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. Am J Kidney Dis 45 (2005) 54-65
21. Wada T., Furuichi K., Segawa-Takaeda C., et al. MIP-1alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 56 (1999) 995-1003
22. Ishida Y., Kimura A., Takayasu T., et al. Detection of fibrocytes in human skin wounds and its application for wound age determination. Int J Legal Med 123 (2009) 299-304
23. Saunders R., Siddiqui S., Kaur D., et al. Fibrocyte localization to the airway smooth muscle is a feature of asthma. J Allergy Clin Immunol 123 (2009) 376-384
24. Abu El-Asrar A.M., Struyf S., Van Damme J., et al. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol 92 (2008) 699-704
25. Hohenstein B., Daniel C., Hausknecht B., et al. Correlation of enhanced thrombospondin-1 expression, TGF-beta signalling and proteinuria in human type-2 diabetic nephropathy. Nephrol Dial Transplant 23 (2008) 3880-3887
26. Wada T., Furuichi K., Sakai N., et al. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 15 (2004) 940-948
27. Wada T., Furuichi K., Sakai N., et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 58 (2000) 1492-1499
28. Sordi V. Mesenchymal stem cell homing capacity. Transplantation 87 (2009) S42-S45
29. Wada T., Furuichi K., Sakai N., et al. Involvement of p38 mitogen-activated protein kinase followed by chemokine expression in crescentic glomerulonephritis. Am J Kidney Dis 38 (2001) 1169-1177
30. Iwata Y., Wada T., Furuichi K., et al. p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice. J Am Soc Nephrol 14 (2003) 57-67
31. Lim A.K., Nikolic-Paterson D.J., Ma F.Y., et al. Role of MKK3-p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. Diabetologia 52 (2009) 347-358
32. Hong K.M., Belperio J.A., Keane M.P., et al. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem 282 (2007) 22910-22920
33. Pfeffer M.A., Swedberg K., Granger C.B., et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362 (2003) 759-766
34. Brenner B.M., Cooper M.E., de Zeeuw D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345 (2001) 861-869
35. Moeller A., Gilpin S.E., Ask K., et al. Circulating Fibrocytes Are an Indicator for Poor Prognosis in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 179 (2009) 588-594